How biologics teams use Dynamic Light Scattering to identify leading candidates

April 17, 2023

Groups in early biologics development and formulation use Dynamic Light Scattering (DLS) to make informed decisions that de-risk downstream biologics development.

Watch this 15 min video to get an overview of how DLS works and how it improves these biologics development processes.

You'll learn:

  • What DLS measures and how it works during a quick refresher
  • What DLS data tells you about your biologics
  • How DLS data from samples with strong or poor colloidal stability looks like
  • How to use DLS to remove candidates with no promise so you can focus on candidates and conditions that have potential

At the end, you'll understand how and when you can add DLS to your early development workflow to de-risk candidate selection.

Why it's important for biologics researchers:

A successful biologic candidate screening campaign depends on having the right tools. When tasked with identifying the most promising biologics candidates, adding DLS gives you more detailed and reliable insights into the purity and colloidal stability of your samples.

To get more detailed information about the physical principles behind Dynamic Light Scattering watch this webinar.

Previous Video
How to use light scattering techniques to predict your biologic's self-association behavior at high concentrations
How to use light scattering techniques to predict your biologic's self-association behavior at high concentrations

Developability work requires the assessment of multiple critical quality attributes (CQAs) of your biologic...

Up next
Overcome bottlenecks in viral vector manufacturing
Overcome bottlenecks in viral vector manufacturing

The success of your gene therapy vectors is dependent on optimal formulation conditions. Finding a buffer t...